Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
ningetinib (CT053PTSA)
i
Other names:
CT053PTSA, CT-053, CT-053-PTSA
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
HEC Pharm
Drug class:
Multi-tyrosine kinase inhibitor
Related drugs:
‹
dasatinib (215)
sorafenib (180)
anlotinib (139)
sunitinib (139)
ponatinib (98)
lenvatinib (90)
pazopanib (76)
gilteritinib (75)
cabozantinib tablet (74)
regorafenib (65)
midostaurin (51)
repotrectinib (27)
vandetanib (26)
cabozantinib capsule (24)
nintedanib (18)
TT-00420 (16)
pexidartinib (6)
SHR 1020 (5)
MGCD516 (5)
AEE788 (4)
APG-2449 (4)
donafenib (2)
AMG 706 (2)
vorolanib (1)
HA121-28 (1)
SY-707 (1)
sorafenib nanoparticle (0)
masitinib (0)
TSN084 (0)
TAS-115 (0)
SKLB-1028 (0)
dasatinib (215)
sorafenib (180)
anlotinib (139)
sunitinib (139)
ponatinib (98)
lenvatinib (90)
pazopanib (76)
gilteritinib (75)
cabozantinib tablet (74)
regorafenib (65)
midostaurin (51)
repotrectinib (27)
vandetanib (26)
cabozantinib capsule (24)
nintedanib (18)
TT-00420 (16)
pexidartinib (6)
SHR 1020 (5)
MGCD516 (5)
AEE788 (4)
APG-2449 (4)
donafenib (2)
AMG 706 (2)
vorolanib (1)
HA121-28 (1)
SY-707 (1)
sorafenib nanoparticle (0)
masitinib (0)
TSN084 (0)
TAS-115 (0)
SKLB-1028 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
MET amplification
Non Small Cell Lung Cancer
MET amplification
Non Small Cell Lung Cancer
gefitinib + CT053PTSA
Sensitive: C2 – Inclusion Criteria
gefitinib + CT053PTSA
Sensitive
:
C2
gefitinib + CT053PTSA
Sensitive: C2 – Inclusion Criteria
gefitinib + CT053PTSA
Sensitive
:
C2
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.